OSTEOARTHRITIS
Comparing intraarticular triamcinolone hexacetonide vs saline for knee OA
Ann Rheum Dis. 1995 May;54(5):379-8184 patients with knee osteoarthritis were randomized to intraarticular injection of either triamcinolone hexacetonide or placebo saline. The purpose of this study was to compare pain and functional outcomes between groups after 1- and 6-week follow-up. Results on pain scores demonstrate a significant reduction in pain after 1 and 6 weeks within both group, with significantly greater reduction in pain between baseline and 1 week documented in the triamcinolone hexacetonide group. Over 6 weeks, results for one-minute walk tests significantly improved within both groups, with no significant between-group differences reported.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
